Clinical outcomes and a therapeutic indication of intramedullary spinal cord astrocytoma.

The most beneficial therapeutic strategy for low-grade astrocytomas was GTR, whereas that for the high-grade tumors was unclear. Further studies with a larger sample size are warranted to validate the effective treatment for malignant astrocytomas.